Why is Sai Life falling/rising?

As of 16-Sep, Sai Life Sciences Ltd is currently priced at 881.90, reflecting a slight increase of 0.85 (0.1%). The stock has been on an upward trend, gaining for the last six consecutive days, with a total return of 3.27% during this period. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating strong momentum. Additionally, the stock has shown a year-to-date return of 17.39%, significantly outperforming the Sensex, which has only increased by 5.43%. Positive factors contributing to this rise include a low Debt to EBITDA ratio of 1.25 times, strong operating profit growth at an annual rate of 87.31%, and impressive net sales growth of 17.67%. Furthermore, the company has reported positive results for the last two consecutive quarters, with a substantial increase in profit after tax and net sales, alongside a notable increase in institutional holdings.
In the broader market context, Sai Life's short-term performance of +2.82% over the past week surpasses the Sensex's increase of +1.58%, indicating that the stock is gaining traction relative to the benchmark. This outperformance can be attributed to rising investor participation, as evidenced by a 5.12% increase in delivery volume, suggesting growing interest in the stock. The liquidity of the stock also supports its tradeability, with a sufficient average traded value. Overall, the combination of strong financial performance, positive investor sentiment, and favorable market conditions appears to be driving the stock's recent upward movement.